The Association between Body Mass Index and Mortality in Breast Cancer Patients Receiving Pembrolizumab [0.03%]
体重指数与帕博利珠单抗治疗乳腺癌患者生存率之间的关系
Cho-Han Chiang,Xiaocao Xu,Ahmed Shahid et al.
Cho-Han Chiang et al.
Introduction: A higher body mass index (BMI) has been associated with a better response and overall survival in patients with lung cancer or melanoma receiving immune checkpoint inhibitors (ICIs). Pembrolizumab has been a...
The Potential of ESCO2 as a Prognostic and Immunotherapeutic Marker of Pan-Cancer and Its Role in Anti-PD-1 Treatment of Bladder Cancer [0.03%]
ESCO2作为泛癌预后和免疫治疗标志物的潜力及其在膀胱癌抗PD-1治疗中的作用
Wei Guo,Shuo Zhao,Keqiang Yan et al.
Wei Guo et al.
Introduction: Establishment of sister chromatid cohesion N-acetyltransferase 2 (ESCO2), a member of the EFO2 family, is implicated in the pathogenesis and progression of various cancers. However, there has been limited co...
First-Line Durvalumab plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice [0.03%]
Durvalumab联合Tremelimumab一线治疗不可切除肝细胞癌的中国真实世界研究
Yasutoshi Fujii,Tomokazu Kawaoka,Yuki Shirane et al.
Yasutoshi Fujii et al.
Introduction: Durvalumab plus tremelimumab combination therapy (STRIDE regimen) is a new first-line option for unresectable hepatocellular carcinoma (uHCC), but little real-world data are available to determine which pati...
Risk for Second Primary Ovarian Cancer: A Large Population Based on Surveillance, Epidemiology, and End Results Database [0.03%]
基于SEER数据库的大样本继发性卵巢癌危险因素分析
Haiyang Hu,Yangsheng Ren,Huixing Li et al.
Haiyang Hu et al.
Introduction: This study aims to evaluate the likelihood of developing a second primary ovarian cancer (OC) considering factors including age, race, and the types of initial malignancies encountered. ...
Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma [0.03%]
TACC3在泛癌中的预后和免疫治疗作用及其对肺腺癌增殖和多西他赛耐药性的影响
Jianyu Xu,Ying Zhu,Qian Liu et al.
Jianyu Xu et al.
Introduction: Transforming acidic coiled-coil containing protein 3 (TACC3) exerts a vital role in cancer progression by modulating cell division and facilitating tumor growth. Given the lack of comprehensive research on t...
Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study [0.03%]
与EB病毒感染相关的胃癌的临床病理特征及 perioperative治疗：回顾性研究
Zhi Ji,Lila Zhu,Xia Wang et al.
Zhi Ji et al.
Introduction: The clinicopathological characteristics and efficacy of perioperative treatment of Epstein-Barr virus-associated gastric cancer (EBVaGC) were investigated. ...
Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study [0.03%]
晚期或不适合中期肝细胞癌经导管动脉化疗免疫治疗后转换疗法的预后评估：一项队列研究
Li-Fu Kuo,Wen-Chun Liu,Ming-Feng Li et al.
Li-Fu Kuo et al.
Introduction: Patients with advanced-stage or intermediate-stage hepatocellular carcinoma (HCC) unsuitable for transarterial chemoembolization (TACE) had poor prognoses. Recent advancements in hepatic arterial infusion ch...
Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study [0.03%]
营养预后指数作为不可切除的晚期或复发性胃癌患者一线化疗和纳武利尤单抗治疗敏感性的生物标志物：一项多中心研究
Nobuhiro Nakazawa,Akihiko Sano,Yuji Kumakura et al.
Nobuhiro Nakazawa et al.
Introduction: This multicenter study aimed to determine whether the pretreatment prognostic nutrition index (PNI) or a change in the index after two treatment courses could be a biomarker for predicting treatment sensitiv...
Development of an Artificial Intelligence System for Distinguishing Malignant from Benign Soft-Tissue Tumors Using Contrast-Enhanced MR Images [0.03%]
基于对比度增强MR图像区分恶性软组织肿瘤与良性病变的人工智能系统研究
Toru Hirozane,Masahiro Hashimoto,Hasnine Haque et al.
Toru Hirozane et al.
Introduction: The integration of artificial intelligence (AI) into orthopedics has enhanced the diagnosis of various conditions; however, its use in diagnosing soft-tissue tumors remains limited owing to its complexity. T...
Effects of Atezolizumab plus Bevacizumab on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular Carcinoma [0.03%]
阿特朱单抗联合贝伐珠单抗对肝细胞癌患者骨骼肌体积和心脏功能的影响
Hideki Nagumo,Hidenari Nagai,Koji Higai et al.
Hideki Nagumo et al.
Introduction: Pharmacological treatment of unresectable hepatocellular carcinoma (uHCC) includes sorafenib and lenvatinib, a tyrosine kinase inhibitor, which are linked to low serum levels of carnitine and reduced skeleta...